SI0785794T1 - Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity - Google Patents

Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity

Info

Publication number
SI0785794T1
SI0785794T1 SI9530576T SI9530576T SI0785794T1 SI 0785794 T1 SI0785794 T1 SI 0785794T1 SI 9530576 T SI9530576 T SI 9530576T SI 9530576 T SI9530576 T SI 9530576T SI 0785794 T1 SI0785794 T1 SI 0785794T1
Authority
SI
Slovenia
Prior art keywords
enteric coated
agonistic activity
benzodiazepine derivatives
coated compositions
cck
Prior art date
Application number
SI9530576T
Other languages
English (en)
Slovenian (sl)
Inventor
Elizabeth Ellen Sugg
Original Assignee
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc. filed Critical Glaxo Wellcome Inc.
Publication of SI0785794T1 publication Critical patent/SI0785794T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9530576T 1994-10-14 1995-10-13 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity SI0785794T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420748A GB9420748D0 (en) 1994-10-14 1994-10-14 1,5 benzodiazepine derivatives
PCT/US1995/012829 WO1996011701A1 (en) 1994-10-14 1995-10-13 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
EP95935725A EP0785794B1 (en) 1994-10-14 1995-10-13 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity

Publications (1)

Publication Number Publication Date
SI0785794T1 true SI0785794T1 (en) 2002-08-31

Family

ID=10762855

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530576T SI0785794T1 (en) 1994-10-14 1995-10-13 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity

Country Status (11)

Country Link
EP (1) EP0785794B1 (xx)
JP (1) JP3907700B2 (xx)
AT (1) ATE210986T1 (xx)
AU (1) AU3763495A (xx)
DE (1) DE69524781T2 (xx)
DK (1) DK0785794T3 (xx)
ES (1) ES2170168T3 (xx)
GB (1) GB9420748D0 (xx)
PT (1) PT785794E (xx)
SI (1) SI0785794T1 (xx)
WO (1) WO1996011701A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
JP4530433B2 (ja) * 1996-05-07 2010-08-25 プリヴァ・ディー・ディー 脂質及びグルコースの代謝疾患治療のための方法及び組成物
MA44007A (fr) 2016-02-05 2018-12-19 Denali Therapeutics Inc Inhibiteurs du récepteur interagissant avec protéine kinase 1
LT3552017T (lt) 2016-12-09 2022-05-10 Denali Therapeutics Inc. Junginiai, naudotini kaip ripk1 inhibitoriai
WO2023137035A1 (en) 2022-01-12 2023-07-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR890100827A (el) * 1988-12-21 1991-03-15 Abbott Lab Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
DK0785794T3 (da) 2002-03-18
EP0785794B1 (en) 2001-12-19
JPH10511930A (ja) 1998-11-17
AU3763495A (en) 1996-05-06
PT785794E (pt) 2002-06-28
EP0785794A1 (en) 1997-07-30
JP3907700B2 (ja) 2007-04-18
GB9420748D0 (en) 1994-11-30
ES2170168T3 (es) 2002-08-01
WO1996011701A1 (en) 1996-04-25
DE69524781D1 (de) 2002-01-31
DE69524781T2 (de) 2002-06-20
ATE210986T1 (de) 2002-01-15

Similar Documents

Publication Publication Date Title
IL131818A (en) Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and solvates and their preparation
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
CA2264238A1 (fr) Forme galenique a liberation prolongee de milnacipran
AU7052698A (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
MY125662A (en) Pharmaceutical formulations containing darifenacin
GEP20012549B (en) Pharmaceutical Composition Containing Sumatriptan
HU229443B1 (en) Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
MY118156A (en) Oral compositions of levosimendan.
CA2340054A1 (en) Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles
IL113365A (en) 5-Heterocyclo-1,5-benzodiazepine derivatives their preparation and pharmaceutical compositions containing them
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
SI0785794T1 (en) Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
CA2244357A1 (en) A novel pharmaceutical composition for inhalation containing cr 2039 (andolast)
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
HUP9802605A3 (en) Pharmaceutical compositions containing oral gel capsule formulation of 1,2,4-benzotriazine oxides
ZA935045B (en) Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
IL134194A0 (en) Streptogramines, their preparation and compositions containing them
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
CA2348024A1 (en) Granular, free-flowing pharmaceutical composition, and straw-like dosage form for oral administration thereof
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it